A clinical study of CS1-Targeted CAR-T cells in Relapsed/Refractory multiple myeloma
Ongoing
This investigator-initiated, exploratory clinical trial is designed to evaluate the feasibility, safety, and preliminary antitumor activity of autologous CS1-targeted chimeric antigen receptor T (CAR-T) cells in adults with relapsed or refractory multiple myeloma (MM).
Multiple …
Phase 1 • Sponsor: Qi Junyuan
Last updated Sep 09, 2026 17:00 UTC